Join today and have your say! It’s FREE!
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Nov 08, 2004 6:13pm
268 Views
Post# 8152702

RE: Q3 Results Out

RE: Q3 Results Out I think the most noteworthy portion of the Tunisia paragraph is the fact that "final terms and conditions are being negotiated " Those are pretty strong words, just short of being a completely done deal. It certainly implies that the funding syndicate is in place as well as the framework of the deal. I must admit that this initiative is considerably farther along than I would have expected, the lump sum cash will definitely be welcome !
Bullboard Posts